The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

The implantable blood pressure sensor will now be available to patients with chronic heart failure through the NHS.

Pulse Biosciences, Inc. , a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced its nPulse ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Abbott (NYSE: ABT) has reported new data supporting its Tendyne transcatheter mitral valve replacement (TMVR) system.

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...

Keep tabs on Texas politics and policy with our morning newsletter. The Texas Tribune Independent news. Trusted by Texans. About The Texas Tribune | Staff | Contact | Send a Confidential Tip | Ethics ...

AUSTIN — Gov. Greg Abbott begins his push for an unprecedented fourth term as the dominant constant in Texas politics, armed with more than $90 million in campaign cash, unified GOP backing and ...

Fresh off a 2026 Critics Choice Award win for Best Supporting Actress for Janelle James, Abbott Elementary returns from winter break on Wednesday, January 7, 2026. Season 5 continues with an episode ...

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s Libre app: Libre Assist. Timed to launch during this week’s CES 2026 ...

Abbott Laboratories ABT recently received FDA approval for its Volt PFA System to treat patients battling atrial fibrillation (AFib). The company is expected to begin commercial PFA cases in the ...